TMPRSS2 and neoplasm: Treatment with flutamide, one of the gold-standard treatments of PCa, and TMPRSS2-ERG siRNA results in similar inhibition of tumor growth in tumor-bearing mice, signifying high efficacy of siRNA treatment in impeding PCa progression [38].